全文获取类型
收费全文 | 9309篇 |
免费 | 669篇 |
国内免费 | 27篇 |
专业分类
耳鼻咽喉 | 98篇 |
儿科学 | 418篇 |
妇产科学 | 143篇 |
基础医学 | 1156篇 |
口腔科学 | 272篇 |
临床医学 | 724篇 |
内科学 | 2615篇 |
皮肤病学 | 308篇 |
神经病学 | 626篇 |
特种医学 | 200篇 |
外国民族医学 | 1篇 |
外科学 | 1302篇 |
综合类 | 30篇 |
一般理论 | 14篇 |
预防医学 | 863篇 |
眼科学 | 137篇 |
药学 | 525篇 |
中国医学 | 32篇 |
肿瘤学 | 541篇 |
出版年
2023年 | 53篇 |
2022年 | 133篇 |
2021年 | 285篇 |
2020年 | 133篇 |
2019年 | 284篇 |
2018年 | 354篇 |
2017年 | 226篇 |
2016年 | 211篇 |
2015年 | 240篇 |
2014年 | 339篇 |
2013年 | 421篇 |
2012年 | 589篇 |
2011年 | 669篇 |
2010年 | 369篇 |
2009年 | 301篇 |
2008年 | 492篇 |
2007年 | 498篇 |
2006年 | 455篇 |
2005年 | 489篇 |
2004年 | 386篇 |
2003年 | 440篇 |
2002年 | 412篇 |
2001年 | 298篇 |
2000年 | 335篇 |
1999年 | 238篇 |
1998年 | 82篇 |
1997年 | 67篇 |
1996年 | 63篇 |
1995年 | 50篇 |
1994年 | 45篇 |
1993年 | 30篇 |
1992年 | 139篇 |
1991年 | 115篇 |
1990年 | 86篇 |
1989年 | 85篇 |
1988年 | 78篇 |
1987年 | 74篇 |
1986年 | 64篇 |
1985年 | 65篇 |
1984年 | 41篇 |
1983年 | 28篇 |
1981年 | 17篇 |
1979年 | 22篇 |
1978年 | 14篇 |
1977年 | 21篇 |
1976年 | 13篇 |
1975年 | 13篇 |
1973年 | 18篇 |
1972年 | 14篇 |
1971年 | 16篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
61.
Vicente Valentín Maganto Maite Murillo González María Valentín Moreno 《Clinical & translational oncology》2004,6(7):448-457
Continuous care for the cancer patient is an open concept that is not only applicable only to the terminal stage. Such a simplification
could generate inequities of therapy and discrimination. Historically, oncology services have been structured as networks
dispensing chemotherapy and radiotherapy rather than services dedicated to the integrated care of the cancer patient. This
situation has changed in a continuous and progressive manner over the past few years, as reflected in the latest Spanish Libro
Blanco de Oncología. We are still far from reaching the optimum level of integrated care, possibly because we have not, as
yet, achieved services that are structured and appropriate for the care-needs of the patient and, perhaps, to the lack of
the necessary personnel. We must always make sure that cancer patients receive the best possible treatment, irrespective of
whet-her the disease is in relapse. Oncologists must not “give up”, indicating that, in addition to using the most effective
anticancer treatments available, they should deploy their best knowledge and experience to control the symptoms of cancer
while providing psycho-social help to the patient and family. This is best conducted with a communication that is adjusted
to the changing needs of the patient over the longterm clinical process, and should be provided by a multidisciplinary team,
according to the needs of the patient and the family.
Within a program of integrated care, it is possible to coordinate the existing care structures without creating parallel health
networks so as to cover the needs of the greatest number of cancer patients in advanced stage of the disease. 相似文献
62.
Pedro José Galindo Fernández Julián Illana Moreno Antonio Piñero Madrona Joaquín Sola Pérez Pascual Parrilla Paricio 《Clinical & translational oncology》2004,6(1):45-47
We present a case of hamartoma of the breast. This is an infrequent tumour that requires the correct diagnosis to distinguish it from other histopathology types because it has a better prognosis. The characteristic image from a mammogram is useful in its diagnosis. 相似文献
63.
64.
65.
P. Gallego J.M. Oliver F. Benito J.M. Mesa E. Sanz I. Moreno G. Cordovilla 《Pediatric cardiology》1998,19(4):358-360
A case of unusual longevity to the age of 58 years is reported for a female patient with complete transposition of the great
arteries. The association with a wide atrial septal defect with intact interventricular septum may have contributed to the
long survival without surgery. Factors determining intercirculatory mixing and systemic oxygen saturation may be the high
pulmonary flow, the location of the anatomic communication, sufficient hemoglobin concentration to allow an adequate level
of systemic resistance and recirculated systemic flow, and the belated development of pulmonary vascular disease. 相似文献
66.
67.
68.
69.
70.
Epidermal growth factor receptor (EGFR) in the prognosis of bladder carcinoma. Experience of 5 years